Skip to content
Kalpvruksh Markets
Offline Log in

COHANCENSEOffline

COHANCE LIFESCIENCES · INE03QK01018 · Small Cap · #436
449.00−1.45 (−0.32%)last close · 05 Nov 2026
Prev close
450.45
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹14,803 cr
52-week range · to 05 Nov 2026279.9753.4

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

COHANCE is 40% below its 52-week high, above its 200-day average, ahead of Healthcare by 3.6 pts over 3 months — a Small Cap company, #436 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 200-day average · below its 20 / 50-day averages · 40% below its 52-week high
  • ahead of its industry by 3.6 pts over 3 months · rank 19 of 44 in Healthcare · +6.9% vs Nifty 500
  • traded value 0.9× usual · delivery 48% vs 46% usual
  • FPI +1.2 pp · DII −1.2 pp · MF schemes in Sept 2026: 26 bought, 43 cut · promoter pledge 94.6% · quarter ended 2026-09-30
  • Jun 2026 quarter: profit a loss · revenue −23%
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹14,803 cr
Rank
#436
Cap band
Small Cap
Nearest cut-off — Mid / Small
−56.70% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
0.8×
median 2,35,000
Delivered
1,98,621
Of volume
55%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week−6.7%−11.9 pts—
1 month−1.8%−6.1 pts−5.5 pts
3 months+4.6%+6.9 pts+3.6 pts
6 months−6.7%−7.1 pts−15.9 pts
1 year−42.4%−40.8 pts—

Industry: Healthcare (Nifty 500 classification) · rank 19 of 44 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
−1.2%
below
vs 50-day average
−0.7%
below
vs 200-day average
+9.6%
above
ATR (14)
3.6%
typical daily range
Volatility
38%
1 month, annualised
Beta
0.97
vs Nifty 500, 1 year
Traded value
0.9×
vs usual
Delivery
48%
usual 46%
From the 52-week high
−40.4%
place in range 36% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters57.5%57.5%57.5%57.5%
FPI6.0%5.6% −0.46.5% +0.97.7% +1.2
Mutual funds17.4%18.6% +1.218.2% −0.416.9% −1.3
Other DII4.2%3.2% −1.01.9% −1.31.9% +0.1
Individuals6.8%7.0% +0.37.7% +0.77.5% −0.2
Others8.2%8.1% −0.18.2% +0.18.5% +0.3

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
94.6%
Of all shares
54.4%
Jun 25 noneSep 25 noneDec 25 noneMar 26 noneJun 26 94.6%Sep 26 94.6%

Holders

Sep 26

All shareholders
93,846
Individuals
89,146

Indian passive funds’ stake

2026-06-30

Of free float
0.81%
Of all shares
0.34%
Schemes
52
Days to unwind
1.2
at 100% of volume

13,13,562 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
108
52 index · 56 active
Bought more
52
Sold some
27
FundSharesChangeDid
SBI Multi Asset Allocation Fund-Reg(G)Active+41,56,513+398.3%bought
UTI MNC Fund-Reg(IDCW)Active+2,59,044+203.3%bought
SBI MNC Fund-Reg(IDCW)Active+12,00,000+120.0%bought
HDFC Pharma and Healthcare Fund-Reg(G)Active−1,78,454−41.7%sold
ICICI Pru Value Fund(G)Active−10,68,024−31.7%sold
JM Flexi Cap Fund-Reg(G)Active−2,21,594−30.7%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 269110163211−2.6%₹2,603 cr
Aug 269210451010−7.5%₹2,744 cr
Jul 2692432152+0.1%₹2,765 cr
Jun 2690234171+2.9%₹2,965 cr
May 2689329186−1.6%₹2,727 cr
Apr 2692542191−3.9%₹3,102 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Insider trades

SEBI PIT disclosures filed with NSE

Promoter group
No market buy or sell
Directors & KMP
No market buy or sell
Others
No market buy or sell
Latest 3 of 3 disclosures
0 selected
19 Sept 2025Jusmiral Holdings LimitedPromotersSell3,41,48,000₹3,094 cr24.15%—
09 May 2025Dr. Venkata Naga Kali Vara Prasada Raju VetukuriDirectorBuy7,13,259₹0.07 cr0.19%Scheme of Amalgamation/Merger/Demerger/Arrangement
09 May 2025Jusmiral Holdings LimitedPromotersBuy12,65,38,578₹12.65 cr33.08%Scheme of Amalgamation/Merger/Demerger/Arrangement

Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.

Disclosures & deals

last six months · NSE filings

  • Credit rating
    Cohance Lifesciences Limited has informed the Exchange about Credit Rating- Others
    13 Aug 2026
  • Board outcome
    Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
    06 Aug 2026

COHANCE: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
EarlierDividend₹1Interim09 Sept 202212 Sept 2022
EarlierDividend₹5Special09 Sept 202212 Sept 2022
EarlierDividend₹1Interim13 May 202217 May 2022
EarlierDividend₹1Interim15 Feb 202216 Feb 2022
EarlierDividend₹2Special15 Feb 202216 Feb 2022
EarlierBonus1:1—25 Sept 202028 Sept 2020

6 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.